Advertisement
Screener

Siga Technologies INC (SIGA) Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares

1.6 / 5 stars · 32/98 Roast Me

Siga Technologies INC Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares

Siga Technologies INC (SIGA) reported Incremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares of 131.26 thousand shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:IncrementalCommonSharesAttributableToContingentlyIssuableShares · last filed 2026-08-06

  • Siga Technologies INC incremental common shares attributable to dilutive effect of contingently issuable shares for the quarter ending 2026-06-30 was 131.26K shares, a 53.68% decline year-over-year.
  • Siga Technologies INC incremental common shares attributable to dilutive effect of contingently issuable shares for the quarter ending 2026-03-31 was 0.00 shares.
  • Siga Technologies INC incremental common shares attributable to dilutive effect of contingently issuable shares for the quarter ending 2025-09-30 was 0.00 shares, a 100.00% decline year-over-year.
  • Siga Technologies INC incremental common shares attributable to dilutive effect of contingently issuable shares for the quarter ending 2025-06-30 was 283.37K shares, a 52.82% decline year-over-year.
  • Siga Technologies INC incremental common shares attributable to dilutive effect of contingently issuable shares for fiscal 2025 was 339.58K shares, a 47.96% decline from fiscal 2024.
  • Siga Technologies INC incremental common shares attributable to dilutive effect of contingently issuable shares for fiscal 2024 was 652.54K shares, a 105.81% increase from fiscal 2023.
  • Siga Technologies INC incremental common shares attributable to dilutive effect of contingently issuable shares for fiscal 2023 was 317.06K shares, a 48.61% decline from fiscal 2022.
  • Siga Technologies INC incremental common shares attributable to dilutive effect of contingently issuable shares for fiscal 2022 was 616.95K shares, a 42.90% decline from fiscal 2021.
Period endIncremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares 3 monthIncremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares 6 monthIncremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares 9 monthIncremental Common Shares Attributable to Dilutive Effect of Contingently Issuable Shares 12 month
2026-06-30131.26K shares
10-Q · filed 2026-08-06
297.04K shares
10-Q · filed 2026-08-06
2026-03-310.00 shares
10-Q · filed 2026-05-07
2025-12-31339.58K shares
10-K · filed 2026-03-10
2025-09-300.00 shares
10-Q · filed 2025-11-06
301.20K shares
10-Q · filed 2025-11-06
2025-06-30283.37K shares
10-Q · filed 2026-08-06
232.21K shares
10-Q · filed 2026-08-06
2025-03-310.00 shares
10-Q · filed 2026-05-07
2024-12-31652.54K shares
10-K · filed 2026-03-10
2024-09-30397.92K shares
10-Q · filed 2025-11-06
662.32K shares
10-Q · filed 2025-11-06
2024-06-30600.66K shares
10-Q · filed 2025-08-05
625.25K shares
10-Q · filed 2025-08-05
2024-03-31469.34K shares
10-Q · filed 2025-05-08
2023-12-31317.06K shares
10-K · filed 2026-03-10
2023-09-300.00 shares
10-Q · filed 2024-11-07
0.00 shares
10-Q · filed 2024-11-07
2023-06-300.00 shares
10-Q · filed 2024-08-01
0.00 shares
10-Q · filed 2024-08-01
2023-03-310.00 shares
10-Q · filed 2024-05-07
2022-12-31616.95K shares
10-K · filed 2025-03-11
2022-09-30235.13K shares
10-Q · filed 2023-11-07
692.66K shares
10-Q · filed 2023-11-07
2022-06-30654.55K shares
10-Q · filed 2023-08-08
825.86K shares
10-Q · filed 2023-08-08
2022-03-31812.49K shares
10-Q · filed 2023-05-04
2021-12-311.08M shares
10-K · filed 2024-03-12
2021-09-300.00 shares
10-Q · filed 2022-11-03
812.25K shares
10-Q · filed 2022-11-03
2021-06-30849.41K shares
10-Q · filed 2022-08-04
847.76K shares
10-Q · filed 2022-08-04
2021-03-31815.58K shares
10-Q · filed 2022-05-05
2020-12-31178.31K shares
10-K · filed 2023-03-02
2020-09-3087.61K shares
10-Q · filed 2021-11-04
171.28K shares
10-Q · filed 2021-11-04
2020-06-30176.17K shares
10-Q · filed 2021-08-05
169.41K shares
10-Q · filed 2021-08-05
2020-03-310.00 shares
10-Q · filed 2021-05-06
2019-12-311.14M shares
10-K · filed 2022-03-03
2019-09-301.12M shares
10-Q · filed 2020-11-05
1.16M shares
10-Q · filed 2020-11-05
2019-06-301.13M shares
10-Q · filed 2020-08-06
1.18M shares
10-Q · filed 2020-08-06
2019-03-311.23M shares
10-Q · filed 2020-05-06
2018-12-312.79M shares
10-K · filed 2021-03-04
2018-09-302.91M shares
10-Q · filed 2019-11-05
3.09M shares
10-Q · filed 2019-11-05
2018-06-302.07M shares
10-Q · filed 2019-08-06
0.00 shares
10-Q · filed 2019-08-06
2018-03-310.00 shares
10-Q · filed 2019-05-02
2017-12-310.00 shares
10-K · filed 2019-03-06
0.00 shares
10-K · filed 2020-03-05
2017-09-300.00 shares
10-Q · filed 2018-11-06
0.00 shares
10-Q · filed 2018-11-06
2016-12-310.00 shares
10-K · filed 2019-03-06

Similar stocks

Stock NameCountryMarket CapPE Ratio
Sionna Therapeutics, Inc. (SION)United States$0.236B-20.37
Cartesian Therapeutics, Inc. (RNAC)United States$0.231B-2.04
Keros Therapeutics, Inc. (KROS)United States$0.229B-2.55
Camp4 Therapeutics Corp (CAMP)United States$0.240B-2.12
NATURES SUNSHINE PRODUCTS INC (NATR)United States$0.228B20.51
MACROGENICS INC (MGNX)United States$0.242B-20.11
Cue Biopharma, Inc. (CUE)United States$0.243B-1.01
Entrada Therapeutics, Inc. (TRDA)United States$0.243B-1.73
Pyxis Oncology, Inc. (PYXS)United States$0.244B
Whitehawk Therapeutics, Inc. (WHWK)United States$0.221B